MeSH term
Frequency | Condition_Probility | *Transcription Factors | 15 | 0.0 |
Binding Sites | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Humans | 44 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 32 | 4.0 |
*Repressor Proteins | 24 | 2.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
*Signal Transduction | 6 | 0.0 |
Trans-Activators/*metabolism | 5 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Survival | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Down-Regulation | 5 | 0.0 |
Flow Cytometry | 3 | 0.0 |
RNA/metabolism | 2 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Signal Transduction | 13 | 0.0 |
Time Factors | 5 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Up-Regulation | 3 | 0.0 |
Carrier Proteins/genetics/metabolism | 3 | 1.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Phosphorylation | 8 | 0.0 |
Protein Transport | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 7 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
Carrier Proteins/genetics/*metabolism | 3 | 0.0 |
*DNA-Binding Proteins | 6 | 0.0 |
Female | 10 | 0.0 |
Pregnancy | 2 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
*Trans-Activators | 6 | 0.0 |
Animals | 20 | 0.0 |
Carrier Proteins/*metabolism | 4 | 0.0 |
Cytokines/*metabolism | 4 | 1.0 |
DNA-Binding Proteins/metabolism | 7 | 0.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
Signal Transduction/*physiology | 5 | 0.0 |
Trans-Activators/metabolism | 7 | 0.0 |
Base Sequence | 6 | 0.0 |
Carrier Proteins/*genetics | 5 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Comparative Study | 5 | 0.0 |
*DNA Methylation | 6 | 0.0 |
DNA Primers | 5 | 0.0 |
Repressor Proteins/*genetics | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Cell Line | 11 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Mice | 14 | 0.0 |
*Milk Proteins | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Carrier Proteins/*physiology | 2 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proteins/*physiology | 2 | 1.0 |
Carrier Proteins/genetics/*physiology | 2 | 2.0 |
Cytokines/*physiology | 2 | 1.0 |
Hydrolysis | 2 | 0.0 |
Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 5 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Amino Acid Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Male | 8 | 0.0 |
Rats | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Ubiquitins/metabolism | 3 | 2.0 |
Carrier Proteins/metabolism | 5 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Repressor Proteins/metabolism | 3 | 1.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Cysteine Endopeptidases/metabolism | 2 | 0.0 |
Multienzyme Complexes/metabolism | 2 | 1.0 |
Oncogene Proteins, Fusion/*metabolism | 2 | 10.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
*Proto-Oncogene Proteins | 3 | 0.0 |
Cell Division | 3 | 0.0 |
Transfection | 10 | 0.0 |
src Homology Domains | 3 | 0.0 |
Adult | 6 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Middle Aged | 5 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Receptors, Interleukin-2/metabolism | 2 | 1.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Tyrosine/chemistry | 2 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
Proteins/genetics | 4 | 0.0 |
Signal Transduction/*immunology | 2 | 0.0 |
DNA Methylation | 5 | 0.0 |
Gene Silencing | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Methylation | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 2 | 1.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Acute Disease | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Carrier Proteins/genetics | 3 | 0.0 |
Interleukin-6/genetics/*metabolism | 2 | 11.0 |
CpG Islands | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
